Advertisement
Advertisement
CVS
CVS HEALTH CORPORATION
79.96
USDSponsored
-11.45
-12.53%
Nov 04, 15:59 UTC -5
Closed
Pre-Market
80.66
+0.70
+0.87%
CVS HEALTH CORPORATION (CVS) Earnings
CVS Earnings Reports
Positive Surprise Ratio
CVS beat 41 of 43 last estimates.
95%
Next Report
Date of Next Report
Feb 08, 2027
Estimate for Q4 26 (Revenue/ EPS)
$107.93B
/$1.25
Implied change from Q3 26 (Revenue/ EPS)
-0.43%
/-40.19%
Implied change from Q4 25 (Revenue/ EPS)
+2.12%
/+14.68%
CVS HEALTH CORPORATION earnings per share and revenue
On Nov 04, 2026, CVS reported earnings of 2.09 USD per share (EPS) for Q3 26, beating the estimate of 1.66 USD, resulting in a 25.37% surprise. Revenue reached 108.40 billion, compared to an expected 105.74 billion, with a 2.51% difference. The market reacted with a -12.53% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 1.25 USD, with revenue projected to reach 107.93 billion USD, implying an decrease of -40.19% EPS, and decrease of -0.43% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Cencora, Inc.
Report Date
Nov 04, 2026 For Q4 26
Estimate
$4.62
Actual
$4.66
Surprise
+0.75%
Revvity, Inc.
Report Date
Nov 03, 2026 For Q3 26
Estimate
$1.32
Actual
$1.38
Surprise
+4.09%
Charles River Laboratories International, Inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
$3.00
Actual
$3.09
Surprise
+2.90%
Caris Life Sciences, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.03
Actual
$0.05
Surprise
+52.91%
Sotera Health Company Common Stock
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.27
Actual
$0.28
Surprise
+6.89%
Progyny, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.31
Actual
$0.52
Surprise
+62.70%
Ardent Health, Inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.22
Actual
$0.31
Surprise
+40.46%
agilon health, inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$1.20
Actual
$1.97
Surprise
+263.44%
InnovAge Holding Corp. Common Stock
Report Date
Nov 03, 2026 For Q1 27
Estimate
$0.08
Actual
$0.14
Surprise
+71.57%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.16
Surprise
-12.04%
FAQ
What were CVS HEALTH CORPORATION's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, CVS HEALTH CORPORATION reported EPS of $2.09, beating estimates by 25.37%, and revenue of $108.40B, 2.51% above expectations.
How did the market react to CVS HEALTH CORPORATION's Q3 2026 earnings?
The stock price moved down -12.53%, changed from $91.41 before the earnings release to $79.96 the day after.
When is CVS HEALTH CORPORATION expected to report next?
The next earning report is scheduled for Feb 08, 2027.
What are the forecasts for CVS HEALTH CORPORATION's next earnings report?
Based on --
analysts, CVS HEALTH CORPORATION is expected to report EPS of $1.25 and revenue of $107.93B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.